Amide-Type Adduct of Dopamine – Plausible Cause of Parkinson Diseases

作者: Xuebo Liu , Naruomi Yamada , Toshihiko Osawa

DOI: 10.1007/978-94-007-7920-4_4

关键词: Docosahexaenoic acidInternal medicineCatecholamineEndocrinologyChemistryDopamineDopamine receptorOxidative stressLipid peroxidationArachidonic acidNeurotransmitter

摘要: Dopamine is the endogenous neurotransmitter produced by nigral neurons. loss can trigger not only prominent secondary morphological changes, but also changes in density and sensitivity of dopamine receptors; therefore, it a sign PD development. The reasons for are attributed to dopamine’s molecular instability due member catecholamine family, whose catechol structure contributes high oxidative stress through enzymatic non-enzymatic oxidation. Oxidative brain easily leads lipid peroxidation reaction concentration polyunsaturated fatty acids (PUFA), such as docosahexaenoic acid (DHA, C22:6/ω-3) arachidonic (AA, C18:4/ω-6). Recent studies have shown that hydroperoxides, primary peroxidative products, could non-specifically react with amino groups form N-acyl-type (amide-linkage) adducts. Therefore, based on NH2-teminals structure, aims this chapter describes possibility reactive LOOH species derived from DHA/AA may modify amide-linkage adducts, which might be related etiology Parkinson’s diseases.

参考文章(65)
E Diez, F H Chilton, G Stroup, R J Mayer, J D Winkler, A N Fonteh, Fatty acid and phospholipid selectivity of different phospholipase A2 enzymes studied by using a mammalian membrane as substrate Biochemical Journal. ,vol. 301, pp. 721- 726 ,(1994) , 10.1042/BJ3010721
Kazumasa Wakamatsu, Kenichi Fujikawa, Fabio A. Zucca, Luigi Zecca, Shosuke Ito, The structure of neuromelanin as studied by chemical degradative methods. Journal of Neurochemistry. ,vol. 86, pp. 1015- 1023 ,(2003) , 10.1046/J.1471-4159.2003.01917.X
Christos Chinopoulos, Vera Adam-Vizi, Calcium, mitochondria and oxidative stress in neuronal pathology FEBS Journal. ,vol. 273, pp. 433- 450 ,(2006) , 10.1111/J.1742-4658.2005.05103.X
Elisabeth Leroy, Rebecca Boyer, Georg Auburger, Barbara Leube, Gudrun Ulm, Eva Mezey, Gyongyi Harta, Michael J. Brownstein, Sobhanadditya Jonnalagada, Tanya Chernova, Anindya Dehejia, Christian Lavedan, Thomas Gasser, Peter J. Steinbach, Keith D. Wilkinson, Mihael H. Polymeropoulos, The ubiquitin pathway in Parkinson's disease Nature. ,vol. 395, pp. 451- 452 ,(1998) , 10.1038/26652
Stanley I. Rapoport, Ying Qu, Lisa Chang, Justin Klaff, Ruth Seeman, Andrea Balbo, Imaging of brain serotonergic neurotransmission involving phospholipase A2 activation and arachidonic acid release in unanesthetized rats. Brain Research Protocols. ,vol. 12, pp. 16- 25 ,(2003) , 10.1016/S1385-299X(03)00057-6
Nicolas G Bazan, Ricardo Palacios-Pelaez, Walter J Lukiw, Hypoxia Signaling to Genes: Significance in Alzheimer's Disease Molecular Neurobiology. ,vol. 26, pp. 283- 298 ,(2002) , 10.1385/MN:26:2-3:283
Luigi Zecca, Moussa B. H. Youdim, Peter Riederer, James R. Connor, Robert R. Crichton, Iron, brain ageing and neurodegenerative disorders Nature Reviews Neuroscience. ,vol. 5, pp. 863- 873 ,(2004) , 10.1038/NRN1537
S.-L. Ang, Transcriptional control of midbrain dopaminergic neuron development. Development. ,vol. 133, pp. 3499- 3506 ,(2006) , 10.1242/DEV.02501